|
Conference Program
Wednesday, November 17, 2010
|
|
7:15 a.m.
|
Registration & Continental Breakfast
|
|
|
8:15 a.m.
|
Welcome
Opening Remarks
|
Raju Kucherlapati, Ph.D.
Professor of Genetics, Professor of Medicine, Harvard Medical School (confirmed)
Scott Weiss, M.D., M.S.
Scientific Director, Partners Center for Personalized Genetic Medicine, Professor of Medicine, Harvard Medical School (confirmed)
Elizabeth Nabel, M.D.
President, Brigham and Women’s Hospital, Faulkner Hospital (confirmed)
|
|
9:00 a.m.
|
Keynote
|
Mikael Dolsten, M.D., Ph.D.
President, Pfizer Worldwide Research & Development (confirmed)
Introducer: Deborah Dunsire, M.D.
President & Chief Executive Officer, Millennium: The Takeda Oncology Company (confirmed)
|
|
9:30 a.m.
|
Networking Break
|
|
|
10:15 a.m.
|
Panel: The Cost and Value of Personalized Medicine in the Era of Reform
|
Jane Barlow
Vice President, Medical Strategy & Clinical Quality, Medco (confirmed)
Harlan Levine, M.D.
Principal, Towers Watson (confirmed)
Sharon Levine
Associate Executive Director, Permanente Medical Group (confirmed)
Arnold Milstein, M.D., M.P.H.
Chief Physician and US Thought Leader, Mercer Health & Benefits (confirmed)
|
|
11:20 a.m.
|
Presentation of Personalized Medicine Coalition’s Sixth Annual Award for Leadership in Personalized Medicine
|
[in amphitheater]
|
|
11:50 a.m.
|
Luncheon
|
[in break-out rooms]
|
|
1:05 p.m.
|
Debate: Patenting Gene Tests: Judge Robert Sweet's Decision
|
Association for Molecular Pathology, et al. v. United States Patent and Trademark Office, et al.
Moderator:
Carolyn Johnson
Science Writer, The Boston Globe (confirmed)
Attorney for the Plaintiffs:
Christopher A. Hansen, Esq.
Senior National Staff Counsel, American Civil Liberties Union (confirmed)
Attorney for the Defendants:
Jennifer Gordon
Partner, Baker Botts LLP (confirmed)
|
|
1:50 p.m.
|
Keynote: An International Perspective
|
Charles Swanton, Ph.D.
Head, Translational Cancer Therapeutics, London branch, Cancer Research UK (confirmed)
|
|
2:20 p.m.
|
Panel: Implementation of Personalized Medicine in Diverse Sectors
|
Mark Boguski, M.D., Ph.D.
Department of Pathology, Beth Israel Deaconess Medical Center (confirmed)
Michael Bristow, M.D., Ph.D.
Chief Executive Officer, ARCA biopharma (confirmed)
Clay Marsh, M.D.
Professor, Senior Associate Vice President for Health Sciences Research, Ohio State University (confirmed)
|
|
3:25 p.m.
|
Networking Break
|
|
|
3:55 p.m.
|
Panel: Molecular Diagnostics: From Technologies to Drugs
|
Moderator: Sue Siegel
Partner, MDV-Mohr Davidow Ventures (confirmed)
William Hagstrom
Chief Executive Officer, Crescendo Bioscience (confirmed)
Peter Hirth, Ph.D.
Chief Executive Officer, Plexxikon (confirmed)
Hugh Martin,
Chief Executive Officer, Pacific Biosciences (confirmed)
Ryan Phelan
President, DNA Direct (confirmed)
Mark Stevenson
President & Chief Operating Officer, Life Technologies (confirmed)
|
|
5:00 p.m.
|
Keynote: An International Perspective
|
Guillerme Suarez-Kurtz, M.D., Ph.D.
Head of Pharmacology, Brazilian National Cancer Institute, Coordinator, Brazilian National Pharmacogenomics Network (REFARGEN) (confirmed)
|
|
5:30 p.m.
|
Reception at Elements Café
|
|
|
Conference Program
Thursday, November 18, 2010
|
|
7:30 a.m.
|
Registration & Continental Breakfast
|
|
|
8:15 a.m.
|
Perspectives from The U.S. Department of Health and Human Services
|
Anna Barker, Ph.D.
Deputy Director, Strategic Scientific Initiatives, NIH (confirmed)
Lawrence Lesko, Ph.D.
Director of Clinical Pharmacology, CDER, FDA (confirmed)
|
|
8:55 a.m.
|
Panel: Information Technology Solutions
|
Moderator: Neil de Crescenzo
Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit (confirmed)
Emad Rizk
President, McKesson Health Solutions (confirmed)
Anthony Hess, Ph.D.
Senior Vice President & General Manager, Health Solutions, SAIC (confirmed)
David Hickey
Executive Vice President, Central Laboratory & Global Research & Development, Siemens Healthcare Diagnostics (confirmed)
Katherine Holland
General Manager, Global Life Sciences Industry, IBM (confirmed)
|
|
10:00 a.m.
|
Keynote: A Perspective from an Academic Medical Center
|
William Chin, M.D.
Executive Dean for Research, Harvard Medical School (confirmed)
|
|
10:30 a.m.
|
Break & Setup
|
|
|
11:00 a.m.
|
Radio Broadcast: On Point with Tom Ashbrook (off-site)
|
Host:
Tom Ashbrook
Journalist, WBUR/NPR (confirmed)
Guests:
To be determined
|
|
12:15 p.m.
|
Bag Lunch
|
|
|
1:15 p.m.
|
Briefings:
Investments in Personalized Medicine
|
Christopher-Paul Milne, D.V.M., M.P.H., J.D.
Associate Director, Tufts Center for the Study of Drug Development (confirmed)
Speaker on BIO & Health Advances white paper: To be determined
|
|
1:45 p.m.
|
Keynote: A Personal Perspective
|
To be determined
|
|
2:15 p.m.
|
Interactive Case Studies on Business Strategies for Personalized Medicine
|
Moderators:
Richard Hamermesh, D.B.A.
MBA Class of 1961 Professor of Management Practice, Harvard Business School (confirmed)
Mara Aspinall
President & Chief Executive Officer, On-Q-ity (confirmed)
|
|
|
|
Raju Kucherlapati, Ph.D.
Professor of Genetics, Professor of Medicine, Harvard Medical School (confirmed)
|